Effects of ODM-109 on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis
Clinical trial NCT02487407 · COMPLETED
Trial details
- NCT number
- NCT02487407
- Sponsor
- Orion Corporation, Orion Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2017-05-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.